| Financial Year |
March 31 2023 |
| Monetary Funds |
159,445,183.67 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
201,830,302.66 |
| Advances to Suppliers |
27,740,706.46 |
| Other Receivables |
2,574,651.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
339,278,455.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
51,406,622.97 |
| Total Current Assets |
798,459,354.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
68,242,118.31 |
| Investment Properties |
-- |
| Fixed Assetes |
112,205,380.37 |
| Under-construction Projects |
648,385,245.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
116,273,021.12 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
874,798.69 |
| Deferred Income Tax Assets |
21,689,515.25 |
| Other Non-Current Assets |
42,043,680.00 |
| Sub-Total of Non-Current Assets |
1,019,138,688.58 |
| Total Assets |
1,817,598,042.80 |
| Short-Term Loans |
100,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
424,000.00 |
| Accounts Payable |
139,947,126.29 |
| Accounts Received In Advance |
98,201.42 |
| Employee Compensation Payable |
8,468,097.05 |
| Taxes Payable |
449,204.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,018,157.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,490,648.94 |
| Other Current Liabilities |
1,872,955.98 |
| Sub-Total of Current Liabilities |
275,944,976.30 |
| Long-term Loans |
348,605,833.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
12,459,245.87 |
| Deferred Income Tax Liabilities |
1,299,069.57 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
366,551,275.62 |
| Total Liabilities |
642,496,251.92 |
| Paid-In Capital(Or Share Stock) |
133,333,400.00 |
| Capital Surplus |
816,424,506.06 |
| Surplus Reserve |
31,043,839.87 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
187,904,066.48 |
| Minority Stockholder's Interest |
6,395,978.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,168,705,812.41 |
| Owner's Equity（Stockholder's Equity） |
1,175,101,790.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,817,598,042.80 |
